18 results
8-K
EX-1.2
GOSS
Gossamer Bio, Inc.
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
, packaging, processing, use, distribution, storage, import, export or disposal of any of the Company's product candidates, (collectively the “Health
8-K
EX-1.1
20zd1 r3l
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
10-K
2zgx5m0x
22 Mar 19
Annual report
4:45pm
424B4
ctdtzfoniov
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1/A
EX-1.1
dr0dtiz9 zn
23 Jan 19
IPO registration (amended)
4:39pm
S-1/A
qzfzqj5i96sc
23 Jan 19
IPO registration (amended)
4:39pm
S-1
shesq
21 Dec 18
IPO registration
4:39pm
S-1
EX-10.18
ff55v
21 Dec 18
IPO registration
4:39pm
DRS/A
6o5jkw
29 Nov 18
Draft registration statement (amended)
12:00am
DRS
7156bhe6v6k8i nh
11 Oct 18
Draft registration statement
12:00am
DRS
EX-10.14
s54k454y6i5yvcfe 5d
11 Oct 18
Draft registration statement
12:00am
- Prev
- 1
- Next